TABLE 2.
AM
|
PM
|
||||||
---|---|---|---|---|---|---|---|
Gene Symbol | Description | ID | Old (Control) | Young | Old HS | Old | P value |
Steroid receptors | |||||||
AR | Androgen receptor | 13806207 | 5.81 ± 0.10 | 5.89 ± 0.05 | 5.81 ± 0.08 | 6.42 ± 0.08* | 0.0001 |
ESR1 | Estrogen receptor 1 | 13827480 | 5.54 ± 0.09 | 5.92 ± 0.10 | 5.65 ± 0.06 | 5.86 ± 0.28 | 0.2026 |
ESR2 | Estrogen receptor 2 | 13784393 | 4.64 ± 0.13 | 4.56 ± 0.06 | 4.74 ± 0.11 | 4.50 ± 0.06 | 0.3874 |
PGR | Progesterone receptor | 13658473 | 6.89 ± 0.09 | 7.17 ± 0.08 | 6.75 ± 0.05 | 6.46 ± 0.25 | 0.0090 |
Neuropeptides and receptors | |||||||
GNRH1 | Gonadotropin-releasing hormone 1 | 13790870 | 6.94 ± 0.15 | 7.03 ± 0.16 | 7.10 ± 0.28 | 7.58 ± 0.35 | 0.2997 |
GNRH2 | Gonadotropin-releasing hormone 2 | 13606683 | 5.46 ± 0.11 | 5.38 ± 0.15 | 5.57 ± 0.09 | 5.10 ± 0.16 | 0.1015 |
GNRHR | Gonadotropin-releasing hormone receptor | 13752156 | 4.31 ± 0.40 | 4.27 ± 0.43 | 3.81 ± 0.41 | 5.28 ± 0.75 | 0.2657 |
KISS1 | Kisspeptin | 13589384 | 5.28 ± 0.07 | 5.14 ± 0.15 | 5.18 ± 0.11 | 5.06 ± 0.19 | 0.6768 |
KISS1R | Kisspeptin receptor | 13820906 | 6.18 ± 0.13 | 6.14 ± 0.09 | 6.01 ± 0.14 | 5.93 ± 0.11 | 0.4600 |
OPRK1 | Opioid receptor, kappa 1 | 13791718 | 6.56 ± 0.11 | 6.50 ± 0.12 | 6.82 ± 0.09 | 6.74 ± 0.09 | 0.1592 |
PDYN | Prodynorphin | 13612278 | 6.38 ± 0.10 | 6.50 ± 0.13 | 6.35 ± 0.18 | 6.74 ± 0.19 | 0.3140 |
TAC1 | Tachykinin 1 | 13735408 | 7.63 ± 0.19 | 7.54 ± 0.20 | 7.65 ± 0.09 | 7.64 ± 0.34 | 0.9802 |
TACR1 | Tachykinin receptor 1 | 13644855 | 4.49 ± 0.20 | 4.62 ± 0.12 | 4.67 ± 0.23 | 4.74 ± 0.18 | 0.8168 |
TAC3 | Tachykinin 3 | 13625903 | 6.40 ± 0.28 | 6.53 ± 0.21 | 5.89 ± 0.15 | 6.01 ± 0.47 | 0.3154 |
TACR3 | Tachykinin receptor 3 | 13757467 | 4.48 ± 0.10 | 4.41 ± 0.16 | 4.17 ± 0.08 | 4.38 ± 0.32 | 0.5849 |
Affymetrix GeneChip Rhesus 1.0 ST Arrays were used to profile gene expression in the arcuate nucleus. Values represent means ± SEMs of bi-weighted average signal intensity. AM = morning necropsy; PM = evening necropsy; HS = 6 months of T and DHEA hormone supplementation.
P<0.05, ANOVA with post hoc Bonferroni adjustment, relative to the Old (Control) group.